lomustine has been researched along with Cerebral Primitive Neuroectodermal Tumor in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Supratentorial PNET (sPNET) are rare CNS tumors of embryonal origin arising in children and adults." | 2.74 | Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation? ( Biswas, S; Burke, A; Burnet, NG; Cherian, S; Earl, HM; Hatcher, H; Horan, G; Jefferies, S; Nicholson, J; Williams, D; Williams, M, 2009) |
| "Significant advances in the treatment of medulloblastoma and primitive neuroectodermal tumors have been made in the past three decades." | 2.42 | Medulloblastomas and central nervous system primitive neuroectodermal tumors. ( McLean, TW, 2003) |
| "Lomustine was administered, but 1 year after surgery, the dog exhibited cluster seizures and died." | 1.43 | Case of a miniature dachshund with a primitive neuroectodermal tumor confined to the forebrain region treated with a combination of surgery and chemotherapy. ( Matsunaga, S; Nakamoto, Y; Ozawa, T; Uchida, K; Yamada, A, 2016) |
| "In seven MB/PNET cell lines investigated, MGMT promoter methylation was detected only in D425 human MB cells as assayed by the qualitative methylation-specific PCR and the more quantitative pyrosequencing assay." | 1.37 | Expression of O⁶-methylguanine-DNA methyltransferase in childhood medulloblastoma. ( Arnold, L; Faoro, D; Gerber, NU; Grotzer, MA; Haybaeck, J; Hegi, M; Hürlimann, ML; Mittelbronn, M; Rutkowski, S; Sciuscio, D; Shalaby, T; von Bueren, AO, 2011) |
| "Identification of synchronous brain tumors prompted genetic testing for predisposition to malignancy." | 1.35 | De novo germline TP53 mutation presenting with synchronous malignancies of the central nervous system. ( Brat, DJ; Esiashvili, N; Janss, AJ; Schniederjan, MJ; Shehata, B, 2009) |
| "Supratentorial primitive neuroectodermal tumors (S-PNET) are rare and have a grim prognosis, frequently taking an aggressive course with local relapse and metastatic spread." | 1.33 | Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy. ( Casanova, M; Cefalo, G; Collini, P; Ferrari, A; Fossati-Bellani, F; Gandola, L; Giangaspero, F; Luksch, R; Massimino, M; Meazza, C; Pignoli, E; Podda, M; Poggi, G; Polastri, D; Ravagnani, F; Simonetti, F; Spreafico, F; Terenziani, M, 2006) |
| "Much rarer are PNETs apparently arising in the leptomeninges." | 1.32 | Primary leptomeningeal primitive neuroectodermal tumor. ( Antunes, NL; Begemann, M; Dunkel, IJ; Lis, E; Lyden, D; Rosenblum, MK; Wolden, S, 2003) |
| "The outcome of a child with a primitive neuroectodermal tumors arising supratentorially (SPNET) is not well characterized and may differ from the outcome of a patient with a histologically similar cerebellar tumor (medulloblastoma [MB])." | 1.31 | Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy. ( Janss, AJ; Packer, RJ; Phillips, PC; Reddy, AT; Weiss, HL, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belcher, SM | 1 |
| Burton, CC | 1 |
| Cookman, CJ | 1 |
| Kirby, M | 1 |
| Miranda, GL | 1 |
| Saeed, FO | 1 |
| Wray, KE | 1 |
| Nakamoto, Y | 1 |
| Yamada, A | 1 |
| Uchida, K | 1 |
| Matsunaga, S | 1 |
| Ozawa, T | 1 |
| Biswas, S | 1 |
| Burke, A | 1 |
| Cherian, S | 1 |
| Williams, D | 1 |
| Nicholson, J | 1 |
| Horan, G | 1 |
| Jefferies, S | 1 |
| Williams, M | 1 |
| Earl, HM | 1 |
| Burnet, NG | 1 |
| Hatcher, H | 1 |
| Schniederjan, MJ | 1 |
| Shehata, B | 1 |
| Brat, DJ | 1 |
| Esiashvili, N | 1 |
| Janss, AJ | 2 |
| Faoro, D | 1 |
| von Bueren, AO | 1 |
| Shalaby, T | 1 |
| Sciuscio, D | 1 |
| Hürlimann, ML | 1 |
| Arnold, L | 1 |
| Gerber, NU | 1 |
| Haybaeck, J | 1 |
| Mittelbronn, M | 1 |
| Rutkowski, S | 1 |
| Hegi, M | 1 |
| Grotzer, MA | 1 |
| Begemann, M | 1 |
| Lyden, D | 1 |
| Rosenblum, MK | 1 |
| Lis, E | 1 |
| Wolden, S | 1 |
| Antunes, NL | 1 |
| Dunkel, IJ | 1 |
| McLean, TW | 1 |
| Massimino, M | 1 |
| Gandola, L | 1 |
| Spreafico, F | 1 |
| Luksch, R | 1 |
| Collini, P | 1 |
| Giangaspero, F | 1 |
| Simonetti, F | 1 |
| Casanova, M | 1 |
| Cefalo, G | 1 |
| Pignoli, E | 1 |
| Ferrari, A | 1 |
| Terenziani, M | 1 |
| Podda, M | 1 |
| Meazza, C | 1 |
| Polastri, D | 1 |
| Poggi, G | 1 |
| Ravagnani, F | 1 |
| Fossati-Bellani, F | 1 |
| Cohen, BH | 1 |
| Zeltzer, PM | 1 |
| Boyett, JM | 1 |
| Geyer, JR | 1 |
| Allen, JC | 1 |
| Finlay, JL | 1 |
| McGuire-Cullen, P | 1 |
| Milstein, JM | 1 |
| Rorke, LB | 2 |
| Stanley, P | 1 |
| Goldwein, JW | 1 |
| Radcliffe, J | 1 |
| Johnson, J | 1 |
| Moshang, T | 1 |
| Packer, RJ | 2 |
| Sutton, LN | 1 |
| D'Angio, GJ | 1 |
| Reddy, AT | 1 |
| Phillips, PC | 1 |
| Weiss, HL | 1 |
1 review available for lomustine and Cerebral Primitive Neuroectodermal Tumor
| Article | Year |
|---|---|
Medulloblastomas and central nervous system primitive neuroectodermal tumors.
Topics: Antineoplastic Agents; Central Nervous System Neoplasms; Cerebellar Neoplasms; Cisplatin; Cyclophosp | 2003 |
2 trials available for lomustine and Cerebral Primitive Neuroectodermal Tumor
| Article | Year |
|---|---|
Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Cisp | 2009 |
Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Childrens Cancer Group randomized trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Combined M | 1995 |
8 other studies available for lomustine and Cerebral Primitive Neuroectodermal Tumor
| Article | Year |
|---|---|
Estrogen and soy isoflavonoids decrease sensitivity of medulloblastoma and central nervous system primitive neuroectodermal tumor cells to chemotherapeutic cytotoxicity.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cisplatin; Equol; Estradiol | 2017 |
Case of a miniature dachshund with a primitive neuroectodermal tumor confined to the forebrain region treated with a combination of surgery and chemotherapy.
Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Dog Diseases | 2016 |
De novo germline TP53 mutation presenting with synchronous malignancies of the central nervous system.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma; Choroid Plex | 2009 |
Expression of O⁶-methylguanine-DNA methyltransferase in childhood medulloblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Proliferation; C | 2011 |
Primary leptomeningeal primitive neuroectodermal tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Combined Modality Therapy; Crani | 2003 |
Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Chi | 2006 |
Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma).
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child, Preschool; | 1996 |
Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytoge | 2000 |